Sonic Healthcare Limited (SHL) said that it had priced US$250 million of notes to 13 investors in the United States. Sonic said the funds would be used to repay existing bank debt and extend Sonic’s debt maturity profit. Under the arrangement there were two tranches, with one at seven years, at a fixed coupon of 5.23%. Another US$155 million was for 10 years, at a fixed coupon of 5.73%.

pSivida Corp. (PVA) reported a consolidated net loss of US$1.6 million for the quarter ended September 30, 2009, compared to a consolidated net loss of $471,000 for the quarter ended September 30, 2008. The drug delivery company said the recent result included a $1.5 million non-cash expense for the change in fair value of derivatives associated with the company’s outstanding warrants denominated in Australian dollars, compared to a $1.3 million impairment a year earlier. pSivida said revenues totaled $3.4 million for the September 2009 quarter compared to revenues of $2.8 million the previous corresponding period.